Indoco Remedies (BOM:532612) 3-Year EBITDA Growth Rate : 5.40% (As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies 3-Year EBITDA Growth Rate?

Indoco Remedies's EBITDA per Share for the three months ended in Sep. 2024 was ₹4.54.

During the past 12 months, Indoco Remedies's average EBITDA Per Share Growth Rate was -17.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 5.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 28.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Indoco Remedies was 58.10% per year. The lowest was -21.00% per year. And the median was 11.55% per year.

Competitive Comparison of Indoco Remedies's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indoco Remedies's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Indoco Remedies's 3-Year EBITDA Growth Rate falls into.

Indoco Remedies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Indoco Remedies (BOM:532612) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Indoco Remedies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Indoco Remedies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

INDOCO:India

Address

166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098

Website

https://www.indoco.com

Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines